2m 2m 2m 2m 2m 2m 2m
Guided Therapeut (GTHP)
OTC
$0.23$0.00 (0.00%)
Price as of Jun 03, 2026- $22.1MMarket Cap
- 73.38%1-Year Change
- Medical DevicesIndustry
Guided Therapeut (GTHP)
$0.23$0.00 (0.00%)
Key Performance
More- Earnings Score: N/A
- Momentum Score: 70
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
No data found
Peers
Statistics
MoreDay Range
$0.23
$0.23
$0.23
1-Year Range
$0.13
$0.54
$0.23
Latest Close$0.23
Change
$0.00 (0.00%)
Volume1,485
Market Cap$22.1M
Shares Outstanding96.5M
P/E (TTM)-5.92
Diluted EPS (TTM)-$0.04
Enterprise Value$22.1M
Information as of 06/03/2026
Company Profile
GUIDED THERAPEUTICS INC
https://www.guidedinc.com$22.1M
Market Cap
-$3.2M
Net Income
Sector: Healthcare
Industry: Medical Devices
5835 Peachtree Corners East, Peachtree Corners, GA, United States, 30092
770 242 8723Guided Therapeutics, Inc., a medical technology company, researches, develops, tests, manufactures, sells, and distributes medical devices in the United States and internationally. It offers LuViva, an advanced cervical scan non-invasive cervical cancer detection device that provides less invasive and painless alternative to conventional tests for identifying, screening, and detecting cervical cancers and precancers. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was incorporated in 1992 and is headquartered in Peachtree Corners, Georgia.
Key Executives
- Mark L. Faupel
Current Ownership Distribution
- Other47.0M (61.33%)
- Insiders29.7M (38.67%)
- Institutions0 (0.00%)
- Mutual Funds0 (0.00%)